NASDAQ
Comera Life Sciences Holdings, Inc. (CMRA) has a price/sales ratio of 20.31x as of Friday, May 22, 2026. This represents a 96.13% decrease compared to its 12-month average of 524.21x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.